STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G/A

AVIR Schedule 13G/A filing by Fidelity / FMR

Fidelity / FMR reported beneficial ownership of 12.0K shares, representing 15% of Atea Pharmaceuticals, Inc. in this filing.

FiledMay 6, 2026
Ownership dateMar 31, 2026
Reported shares12.0K
Reported ownership15%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 11.9M
Shared voting power 12.0K
Sole dispositive power 12.0K
Shared dispositive power 12.0K
Price context

Price dates alongside the ownership filing

Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.

Close near filing date$5.65as of May 6, 2026
Latest tracked price$4.75as of Aug 5, 2026
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
Fidelity / FMR
CIK
CIK0000315066
Accession
0000315066-26-001112
Form
Schedule 13G/A
Open SEC filing View AVIR ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →